The contribution of nitric oxide and vasodilatory prostanoids to bradykinin-mediated vasodilation in Type 1 diabetes.
Wotherspoon, F
The contribution of nitric oxide and vasodilatory prostanoids to bradykinin-mediated vasodilation in Type 1 diabetes. [electronic resource] - Diabetic medicine : a journal of the British Diabetic Association Jun 2005 - 697-702 p. digital
Publication Type: Journal Article
0742-3071
10.1111/j.1464-5491.2005.01493.x doi
Adult
Bradykinin--administration & dosage
Diabetes Mellitus, Type 1--physiopathology
Endothelium, Vascular--drug effects
Female
Forearm--blood supply
Humans
Male
Middle Aged
Nitric Oxide--physiology
Prostaglandins--physiology
Regional Blood Flow--drug effects
Vasodilation--drug effects
Vasodilator Agents--pharmacology
The contribution of nitric oxide and vasodilatory prostanoids to bradykinin-mediated vasodilation in Type 1 diabetes. [electronic resource] - Diabetic medicine : a journal of the British Diabetic Association Jun 2005 - 697-702 p. digital
Publication Type: Journal Article
0742-3071
10.1111/j.1464-5491.2005.01493.x doi
Adult
Bradykinin--administration & dosage
Diabetes Mellitus, Type 1--physiopathology
Endothelium, Vascular--drug effects
Female
Forearm--blood supply
Humans
Male
Middle Aged
Nitric Oxide--physiology
Prostaglandins--physiology
Regional Blood Flow--drug effects
Vasodilation--drug effects
Vasodilator Agents--pharmacology